0000950137-05-000617.txt : 20120628 0000950137-05-000617.hdr.sgml : 20120628 20050124120656 ACCESSION NUMBER: 0000950137-05-000617 CONFORMED SUBMISSION TYPE: DFAN14A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20050124 DATE AS OF CHANGE: 20050124 EFFECTIVENESS DATE: 20050124 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PLEXUS CORP CENTRAL INDEX KEY: 0000785786 STANDARD INDUSTRIAL CLASSIFICATION: PRINTED CIRCUIT BOARDS [3672] IRS NUMBER: 391344447 STATE OF INCORPORATION: WI FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: DFAN14A SEC ACT: 1934 Act SEC FILE NUMBER: 000-14824 FILM NUMBER: 05543581 BUSINESS ADDRESS: STREET 1: 55 JEWELERS PARK DR CITY: NEENAH STATE: WI ZIP: 54957-0156 BUSINESS PHONE: 9207223451 MAIL ADDRESS: STREET 1: PLEXUS CORP STREET 2: 55 JEWELERS PARK DR CITY: NEENAH STATE: WI ZIP: 54957-0156 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: PLEXUS CORP CENTRAL INDEX KEY: 0000785786 STANDARD INDUSTRIAL CLASSIFICATION: PRINTED CIRCUIT BOARDS [3672] IRS NUMBER: 391344447 STATE OF INCORPORATION: WI FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: DFAN14A BUSINESS ADDRESS: STREET 1: 55 JEWELERS PARK DR CITY: NEENAH STATE: WI ZIP: 54957-0156 BUSINESS PHONE: 9207223451 MAIL ADDRESS: STREET 1: PLEXUS CORP STREET 2: 55 JEWELERS PARK DR CITY: NEENAH STATE: WI ZIP: 54957-0156 DFAN14A 1 c91360dfan14a.htm ADDITIONAL DEFINITIVE PROXY MATERIAL dfan14a
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No.     )

  Filed by the Registrant   x
  Filed by a Party other than the Registrant   o
 
  Check the appropriate box:

  o   Preliminary Proxy Statement
  o   Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
  o   Definitive Proxy Statement
  x   Definitive Additional Materials
  o   Soliciting Material Pursuant to §240.14a-12

PLEXUS CORPORATION

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

      Payment of Filing Fee (Check the appropriate box):

  o   No fee required.
  o   Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.

        1) Title of each class of securities to which transaction applies:

        2) Aggregate number of securities to which transaction applies:

        3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

        4) Proposed maximum aggregate value of transaction:

        5) Total fee paid:

        o   Fee paid previously with preliminary materials.

        o   Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

        1) Amount Previously Paid:

        2) Form, Schedule or Registration Statement No.:

        3) Filing Party:

        4) Date Filed:

SEC 1913 (11-01) Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

 

January 24, 2005

Board of Directors
Plexus Corp.
55 Jewelers Park Drive
Neenah, WI 54957

     Re: Plexus Corp. 2005 Equity Incentive Plan

Gentlemen:

     As you know, the Plexus Corp. Board has adopted (subject to shareholder approval), and has recommended that Plexus shareholders approve, the Plexus Corp. 2005 Equity Incentive Plan (the “Plan”) at Plexus’ 2005 annual meeting of shareholders. We have received informal feedback regarding the Plan which indicated that there was a concern that one provision, Section 11, may indirectly authorize the “repricing” of stock options or SARs. Section 11 governs, in general, certain vesting consequences in the event of a substitution of an option or SAR.

     Plexus does not believe that the Plan in general, or Section 11 in particular, authorizes or permits the “repricing” of stock options or SARs, nor would a substitution of Awards which would have that effect be authorized or permitted. Section 11 only governs consequences of other action and does not provide authority to reprice or substitute with the effect of repricing. The Plexus proxy statement specifically states, and confirms, that repricing is not permitted.

     However, to eliminate any misunderstanding or misinterpretation, management recommends to the Plexus Board that, assuming the Plan is adopted by shareholders, the Board amend the Plan to add the following proviso at the end of Section 11:

Notwithstanding the foregoing, nothing in this Section 11 shall provide authority to substitute Awards in a manner which will have the effect of repricing Awards to a lower exercise price.

     We will schedule consideration of this amendment at the meeting of the Board which immediately follows the 2005 annual meeting of shareholders, which is the next meeting of the Board.

Very truly yours,

/s/ Joseph D. Kaufman

Joseph D. Kaufman, Senior Vice President,
Chief Legal Officer and Secretary